Vifor Fresenius Medical Care Renal Pharma clinical trials
Acquired by CSL Limited, Aug 9, 2022 · source ↗
The registry lists 9 studies whose lead sponsor is Vifor Fresenius Medical Care Renal Pharma. 1 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 23, 2026.
Before and after it joined CSL Limited
- First submitted before Vifor Fresenius Medical Care Renal Pharma became part of CSL Limited
- 5
- First submitted after Vifor Fresenius Medical Care Renal Pharma became part of CSL Limited
- 4
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Vifor Fresenius Medical Care Renal Pharma9 studies
Something wrong with this grouping? Tell us on the CSL Limited page.
Studies
Recruiting first, then most recently updated. Showing 9 of 9. All CSL Limited studies →
- Safety and Tolerability of Difelikefalin in Adolescents on Haemodialysis With Moderate-to-Severe PruritusRecruitingNCT06593392Phase 2
Sponsor listed in the registry: Vifor Fresenius Medical Care Renal Pharma · First submitted after Vifor Fresenius Medical Care Renal Pharma became part of CSL Limited
- Avacostar - (PASS)Active, not recruitingNCT05897684
Sponsor listed in the registry: Vifor Fresenius Medical Care Renal Pharma · First submitted after Vifor Fresenius Medical Care Renal Pharma became part of CSL Limited
- Trial Evaluating the Efficacy and Safety of Patiromer in Chinese SubjectsCompletedNCT05136664Phase 3
Sponsor listed in the registry: Vifor Fresenius Medical Care Renal Pharma · First submitted before Vifor Fresenius Medical Care Renal Pharma became part of CSL Limited
- Phase 3 Study of Difelikefalin in Haemodialysis Chinese Adult Subjects With Moderate-to-Severe PruritusCompletedNCT05885737Phase 3
Sponsor listed in the registry: Vifor Fresenius Medical Care Renal Pharma · First submitted after Vifor Fresenius Medical Care Renal Pharma became part of CSL Limited
- Pharmacokinetics of Intravenous Difelikefalin in Chinese Adult Subjects on HaemodialysisCompletedNCT05885763Phase 1
Sponsor listed in the registry: Vifor Fresenius Medical Care Renal Pharma · First submitted after Vifor Fresenius Medical Care Renal Pharma became part of CSL Limited
- PA21 Safety and Efficacy in Adult Chinese SubjectsCompletedNCT03644264Phase 3
Sponsor listed in the registry: Vifor Fresenius Medical Care Renal Pharma · First submitted before Vifor Fresenius Medical Care Renal Pharma became part of CSL Limited
- Artificial Intelligence for Optimal Anemia Management in End-stage Renal Disease: The Anemia Control Model (ACM) TrialTerminatedNCT03214627Not applicable
Sponsor listed in the registry: Vifor Fresenius Medical Care Renal Pharma · First submitted before Vifor Fresenius Medical Care Renal Pharma became part of CSL Limited
- Non-interventional Study to Investigate the Short and Long Term Real-life Safety, Effectiveness, and Adherence of Velphoro® in Patients With Hyperphosphataemia Undergoing Haemodialysis (HD) or Peritoneal Dialysis (PD)CompletedNCT02687594
Sponsor listed in the registry: Vifor Fresenius Medical Care Renal Pharma · First submitted before Vifor Fresenius Medical Care Renal Pharma became part of CSL Limited
- A Study to Investigate the Safety and Efficacy of PA21 (Velphoro®) and Calcium Acetate (Phoslyra®) in Paediatric and Adolescent Chronic Kidney Disease (CKD) Patients With HyperphosphataemiaTerminatedNCT02688764Phase 3
Sponsor listed in the registry: Vifor Fresenius Medical Care Renal Pharma · First submitted before Vifor Fresenius Medical Care Renal Pharma became part of CSL Limited